MoneyWorks4Me

Clarification sought from Dishman Pharmaceuticals and Chemicals

17 Nov 2015 Evaluate

The Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals with reference to the news reported on moneycontrol on 17/11/2015 - ‘USFDA gives Warning Letter to Dishman due to Clovis issues’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..